I-SABR-SELECT: A Radiomics-Based Model for Personalized Immunotherapy for Early-Stage NonSmall Cell Lung Cancer

被引：0

作者：

Saad, M. B. ^{[1
]}

Showkatian, E. ^{[1
]}

Al-Tashi, Q. ^{[1
]}

Aminu, M. ^{[1
]}

Xinyan, X. ^{[1
]}

Mohamed, M. Qayati ^{[1
]}

Salehjahromi, M. ^{[1
]}

Sujit, S. J. ^{[1
]}

Lin, S. H. ^{[2
]}

Liao, Z. ^{[2
]}

Gandhi, S. ^{[2
]}

Qian, D. ^{[2
]}

Jaffray, D. A. ^{[1
,3
]}

Chung, C. ^{[2
,3
]}

Vokes, N. ^{[4
]}

Zhang, J. ^{[4
]}

Heymach, J. V. ^{[4
]}

Wu, J. ^{[1
,3
,4
]}

Chang, J. Y. ^{[2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX USA

[3] Univ Texas MD Anderson Canc Ctr, Inst Data Sci Oncol, Houston, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期

关键词：

SABR; Immunotherapy; Radiomics;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OA13.05

引用

页码：S40 / S40

页数：1

共 50 条

[21] Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
Shukla, Nikhil
Hanna, Nasser
LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 51 - 60
[22] Study design and early result of a phase I study of SABR for early-stage glottic cancer
Yu, Tosol
Wee, Chan Woo
Choi, Noorie
Wu, Hong-Gyun
Kang, Hyun-Cheol
Park, Jong Min
Kim, Jung-In
Kim, Jin Ho
Kwon, Tack-Kyun
Chung, Eun-Jae
LARYNGOSCOPE, 2018, 128 (11): : 2560 - 2565
[23] Artificial intelligence-based radiomics for the prediction of nodal metastasis in early-stage lung cancer
Shimada, Yoshihisa
Kudo, Yujin
Maehara, Sachio
Fukuta, Kentaro
Masuno, Ryuhei
Park, Jinho
Ikeda, Norihiko
SCIENTIFIC REPORTS, 2023, 13 (01)
[24] Artificial intelligence-based radiomics for the prediction of nodal metastasis in early-stage lung cancer
Yoshihisa Shimada
Yujin Kudo
Sachio Maehara
Kentaro Fukuta
Ryuhei Masuno
Jinho Park
Norihiko Ikeda
Scientific Reports, 13
[25] To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer
Shultz, David Benjamin
Diehn, Maximilian
Loo, Billy W., Jr.
SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (02) : 78 - 86
[26] Radiomics-based Prognosis Analysis for Non-Small Cell Lung Cancer
Zhang, Yucheng
Oikonomou, Anastasia
Wong, Alexander
Haider, Masoom A.
Khalvati, Farzad
SCIENTIFIC REPORTS, 2017, 7
[27] Nivolumab After Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Randomized I-SABR Trial
Chang, J. Y.
Lin, S. H.
Dong, W.
Liao, Z.
Gandhi, S.
Chun, S. G.
Gay, C. M.
Zhang, J.
Fossella, F. V.
Blumenschein, G. R.
Cascone, T.
Le, X.
Pozadzides, J. V.
Tsao, A.
Mehmet, A.
Welsh, J. W.
Verma, V.
Wistuba, I. I.
Lee, J.
Heymach, J.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S71 - S71
[28] Discrepancy Between Radiological and Pathological Tumor Size in Early-Stage NonSmall Cell Lung Cancer: A Multicenter Study
Kamigaichi, Atsushi
Tsutani, Yasuhiro
Mimae, Takahiro
Miyata, Yoshihiro
Adachi, Hiroyuki
Shimada, Yoshihisa
Takeshima, Yukio
Ito, Hiroyuki
Ikeda, Norihiko
Okada, Morihito
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2022, 36 (02) : 273 - 281
[29] Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer
Birim, Ö
Kappetein, AP
Goorden, T
van Klaveren, RJ
Bogers, AJJC
ANNALS OF THORACIC SURGERY, 2005, 80 (03): : 1021 - 1027
[30] Identification of MiR-374a as a Prognostic Marker for Survival in Patients with Early-Stage Nonsmall Cell Lung Cancer
Vosa, Urmo
Vooder, Tonu
Kolde, Raivo
Fischer, Krista
Vaelk, Kristjan
Tonisson, Neeme
Roosipuu, Retlav
Vilo, Jaak
Metspalu, Andres
Annilo, Tarmo
GENES CHROMOSOMES & CANCER, 2011, 50 (10): : 812 - 822

← 1 2 3 4 5 →